<DOC>
	<DOCNO>NCT01365546</DOCNO>
	<brief_summary>Proportion surgery primary endpoint ( overall assessment ) classify success .</brief_summary>
	<brief_title>Wilate Subjects With Von Willebrand Disease Who Undergo Surgery</brief_title>
	<detailed_description />
	<mesh_term>Von Willebrand Diseases</mesh_term>
	<criteria>Diagnosed congenital VWD ( von Willebrand Disease ) Require therapy VWF ( von Willebrand Factor ) product treat major surgical procedure Known coagulation disorder VWD Known history , suspect VWF FVIII inhibitor Subjects hepatic liver disease Known suspect hypersensitivity previous evidence severe side effect wilate VWF/FVIII concentrate Pregnant woman first 20 week gestation</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>